Clinical Trials Directory

Trials / Completed

CompletedNCT01970163

DermACELL in Subjects With Chronic Wounds of the Lower Extremities

A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
202 (actual)
Sponsor
LifeNet Health · Industry
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study will compare treatment with DermACELL to conventional care in diabetic foot ulcers (DFU) and venous stasis ulcers (VSU).

Detailed description

This study is designed to demonstrate the effectiveness of DermACELL in the treatment of chronic wounds of the lower extremities. DermACELL will be compared to conventional care in both subjects with diabetic foot ulcers (DFU) and subjects with venous stasis ulcers (VSU). In addition, DermACELL will be compared to an active comparator, GraftJacket, in subjects with diabetic foot ulcers. DermACELL and GraftJacket are both made from donated human skin (dermis). These products have been processed so that cells are removed and bacteria and viruses are destroyed. This processing provided a supporting structure, an acellular dermal matrix, into which cells can migrate and divide during the wound healing process.

Conditions

Interventions

TypeNameDescription
OTHERDermACELLAcellular dermal matrix is applied at Baseline visit. The study product may be reapplied an additional time (between Weeks 2 and 12 for venous stasis ulcers and between Weeks 3 and 12 for diabetic foot ulcers).
OTHERGraftJacketAcellular dermal matrix applied at Baseline visit. May be reapplied one additional time during study (between Week 2 and 12 for venous stasis ulcers and Week 3 and 12 for diabetic foot ulcers).
OTHERConventional Care DressingsDepending on the state of the wound (dry or moist), different types of nonadherent dressings would be utilized as the primary dressing: * If the wound is dry, a nonadherent dressing, such an oil emulsion dressing, may be appropriate, as these dressings tend to donate moisture to the wound. * Hydrogels can also be used if the wound is in need of moisture. * For a wound that is more moist, a more absorptive dressing may be more appropriate to help reduce potential for maceration. A secondary dressing may be desired to add either loft or cushion.

Timeline

Start date
2013-10-01
Primary completion
2016-01-01
Completion
2016-04-01
First posted
2013-10-25
Last updated
2018-03-14

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01970163. Inclusion in this directory is not an endorsement.